Stocktoria
Universe Pharmaceuticals INC UPC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-23
Universe Pharmaceuticals INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $17.9B | $23.0B | $32.3B | $40.1M | $48.0M |
| Gross profit | $6.3B | $6.1B | $10.3B | $21.9M | $25.3M |
| R&D expense | $671.8M | $3.0B | $4.9B | $7.6M | $5.5M |
| Operating income | -$2.9B | -$8.0B | -$4.0B | -$7.0M | $13.6M |
| Interest expense | $289.4M | $304.5M | $190.2M | $162,400 | $101,604 |
| Income tax | — | $606.7M | $2.3B | $815,322 | $2.4M |
| Net income | -$3.7B | -$8.7B | -$6.6B | -$7.9M | $11.3M |
| EPS (diluted) | $-8.06 | $-626.96 | $-1089.21 | $-1309.11 | $3.58 |
| Operating cash flow | -$5.1B | -$9.5B | $1.1B | -$1.3M | -$2.1M |
| Free cash flow | -$5.3B | -$9.7B | $1.1B | -$1.4M | -$2.5M |
| Cash & equivalents | — | — | — | — | $8.1M |
| Inventory | $2.2B | $1.7B | $3.3M | $2.2M | $2.5M |
| Total assets | $69.3B | $68.0B | $41.7M | $59.5M | $70.1M |
| Total liabilities | $13.2B | $22.5B | $13.8M | — | — |
| Shareholders' equity | $56.1B | $45.5B | $28.0B | $35.3B | $47.0M |
Source: SEC EDGAR filings · CIK 0001809616 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.